Dyne Therapeutics 40% Rally Faces Fund Selloff Questions
A dramatic 40% jump for Dyne Therapeutics has investors watching closely as a biotech-focused fund disclosed a sizabl...
Stay ahead with 2024 windfall strategies that optimize payment timing, debt prioritization, and milestone tracking.
11,946 articlesA dramatic 40% jump for Dyne Therapeutics has investors watching closely as a biotech-focused fund disclosed a sizabl...
A hedge fund trend today centers on a lean, two-name portfolio. INDUS Capital Partners boosted its bet on H World Gro...
As the 10-year yield fluctuates and inflation data shape policy bets, homeowners and buyers ask how much higher mortg...
Unlock the essentials of the earn 2025 earnings transcript. This plain‑speak guide breaks down what to listen for, ho...
A new breed of risk is gnawing at fixed-income markets: opaque AI lending and leveraged credit create unseen damage t...
Tech stocks plunge. meanwhile, Costco climbs to fresh all-time highs as investors rotate from high-growth tech to def...
When a seasoned fund doubles down on a single stock, it sends a clear message. Frontier Capital Management recently e...
This article breaks down what the stock market today is telling investors about NIO and the EV sector. Learn how reve...
As inflation remains stubborn, a prominent podcast host argues that sitting on cash erodes real buying power. Investo...
Aging workers and slower inflows of young talent are driving a new 'great mismatch' in the labor market, according to...
A transformative era is unfolding as AI reshapes data centers and digital workloads. This article outlines a practica...
A nationwide labor crunch is tightening the screws on U.S. construction as immigrant workers pull back amid policy ch...